Applied DNA Sciences (APDN) Issues Earnings Results, Misses Estimates By $0.08 EPS

Applied DNA Sciences (NASDAQ:APDN) announced its earnings results on Thursday. The technology company reported ($0.12) earnings per share for the quarter, missing the Zacks’ consensus estimate of ($0.04) by ($0.08), MarketWatch Earnings reports. The company had revenue of $1.20 million during the quarter. Applied DNA Sciences had a negative return on equity of 208.26% and a negative net margin of 299.85%.

Shares of NASDAQ:APDN opened at $0.90 on Friday. Applied DNA Sciences has a one year low of $0.86 and a one year high of $2.70.

Separately, ValuEngine raised shares of Applied DNA Sciences from a “hold” rating to a “buy” rating in a research note on Tuesday, September 11th.

TRADEMARK VIOLATION WARNING: “Applied DNA Sciences (APDN) Issues Earnings Results, Misses Estimates By $0.08 EPS” was reported by WKRB News and is the property of of WKRB News. If you are reading this report on another publication, it was stolen and republished in violation of U.S. & international copyright and trademark legislation. The correct version of this report can be viewed at

About Applied DNA Sciences

Applied DNA Sciences, Inc provides biotechnology based security solutions for supply chain security, brand protection, and law enforcement applications in the United States, Europe, Asia, and internationally. The company's supply chain security and product authentication solutions include SigNature molecular tags that are ingredients used to fortify brand protection efforts and strengthen supply chain security, as well as mark, track, and convict criminals; SigNature T molecular tags, which are tagging and authentication systems for use in brand protection efforts and raw material source compliance programs; and fiberTyping, a test of native cotton fiber DNA.

See Also: Preferred Stock

Earnings History for Applied DNA Sciences (NASDAQ:APDN)

Receive News & Ratings for Applied DNA Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Applied DNA Sciences and related companies with's FREE daily email newsletter.

Leave a Reply